This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v3.0.0: STU 3) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Primary Cancer Disorder Value Set - JSON Representation

Raw json | Download

{
  "resourceType" : "ValueSet",
  "id" : "mcode-primary-cancer-disorder-vs",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This value set includes codes based on the following rules:</p><ul><li>Import all the codes that are contained in <a href=\"ValueSet-mcode-primary-malignant-neoplasm-disorder-vs.html\">Primary Malignant Neoplasm Disorder Value Set</a></li><li>Import all the codes that are contained in <a href=\"ValueSet-mcode-hypereosinophilic-syndrome-disorder-vs.html\">Specific Diagnosis of Cancer Value Set</a></li><li>Import all the codes that are contained in <a href=\"ValueSet-mcode-carcinoma-in-situ-disorder-vs.html\">Carcinoma In-Situ Disorder Value Set</a></li><li>Import all the codes that are contained in <a href=\"ValueSet-mcode-melanoma-in-situ-disorder-vs.html\">Melanoma In-Situ Disorder Value Set</a></li><li>Import all the codes that are contained in <a href=\"ValueSet-mcode-benign-uncertain-neoplasm-brain-cns-disorder-vs.html\">Benign Neoplasm of Brain and CNS Disorder Value Set</a></li><li>Import all the codes that are contained in <a href=\"ValueSet-mcode-cytologic-evidence-malignancy-vs.html\">Cytologic Evidence of Malignancy Value Set</a></li></ul></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
      "valueInteger" : 4
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode" : "cic"
    }
  ],
  "url" : "http://hl7.org/fhir/us/mcode/ValueSet/mcode-primary-cancer-disorder-vs",
  "version" : "3.0.0",
  "name" : "PrimaryCancerDisorderVS",
  "title" : "Primary Cancer Disorder Value Set",
  "status" : "draft",
  "experimental" : false,
  "date" : "2023-10-26T00:01:45+00:00",
  "publisher" : "HL7 International / Clinical Interoperability Council",
  "contact" : [
    {
      "name" : "HL7 International / Clinical Interoperability Council",
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://www.hl7.org/Special/committees/cic"
        },
        {
          "system" : "email",
          "value" : "ciclist@lists.HL7.org"
        }
      ]
    }
  ],
  "description" : "Types of primary malignant neoplastic disease, coded in SNOMED CT or ICD-10-CM.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US",
          "display" : "United States of America"
        }
      ]
    }
  ],
  "copyright" : "This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement",
  "compose" : {
    "include" : [
      {
        "valueSet" : [
          "http://hl7.org/fhir/us/mcode/ValueSet/mcode-primary-malignant-neoplasm-disorder-vs"
        ]
      },
      {
        "valueSet" : [
          "http://hl7.org/fhir/us/mcode/ValueSet/mcode-hypereosinophilic-syndrome-disorder-vs"
        ]
      },
      {
        "valueSet" : [
          "http://hl7.org/fhir/us/mcode/ValueSet/mcode-carcinoma-in-situ-disorder-vs"
        ]
      },
      {
        "valueSet" : [
          "http://hl7.org/fhir/us/mcode/ValueSet/mcode-melanoma-in-situ-disorder-vs"
        ]
      },
      {
        "valueSet" : [
          "http://hl7.org/fhir/us/mcode/ValueSet/mcode-benign-uncertain-neoplasm-brain-cns-disorder-vs"
        ]
      },
      {
        "valueSet" : [
          "http://hl7.org/fhir/us/mcode/ValueSet/mcode-cytologic-evidence-malignancy-vs"
        ]
      }
    ]
  }
}